Dietary iron restriction or iron chelation protects from diabetes and loss of β-cell function in the obese (ob/ob lep−/−) mouse
- 1 June 2010
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 298 (6), E1236-E1243
- https://doi.org/10.1152/ajpendo.00022.2010
Abstract
Iron overload can cause insulin deficiency, but in some cases this may be insufficient to result in diabetes. We hypothesized that the protective effects of decreased iron would be more significant with increased β-cell demand and stress. Therefore, we treated the ob/ob mouse model of type 2 diabetes with an iron-restricted diet (35 mg/kg iron) or with an oral iron chelator. Control mice were fed normal chow containing 500 mg/kg iron. Neither treatment resulted in iron deficiency or anemia. The low-iron diet significantly ameliorated diabetes in the mice. The effect was long lasting and reversible. Ob/ob mice on the low-iron diet exhibited significant increases in insulin sensitivity and β-cell function, consistent with the phenotype in mouse models of hereditary iron overload. The effects were not accounted for by changes in weight or feeding behavior. Treatment with iron chelation had a more dramatic effect, allowing the ob/ob mice to maintain normal glucose tolerance for at least 10.5 wk despite no effect on weight. Although dietary iron restriction preserved β-cell function in ob/ob mice fed a high-fat diet, the effects on overall glucose levels were less apparent due to a loss of the beneficial effects of iron on insulin sensitivity. Beneficial effects of iron restriction were minimal in wild-type mice on normal chow but were apparent in mice on high-fat diets. We conclude that, even at “normal” levels, iron exerts detrimental effects on β-cell function that are reversible with dietary restriction or pharmacotherapy.Keywords
This publication has 39 references indexed in Scilit:
- Wound healing in zebrafishNature, 2009
- Design, Synthesis, and Testing of Non-Nephrotoxic Desazadesferrithiocin Polyether AnaloguesJournal of Medicinal Chemistry, 2008
- Elevated serum ferritin concentrations in prediabetic subjectsDiabetes and Vascular Disease Research, 2008
- Rev-erbα, a Heme Sensor That Coordinates Metabolic and Circadian PathwaysScience, 2007
- Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective studyDiabetologia, 2007
- Heme Iron From Diet as a Risk Factor for Coronary Heart Disease in Women With Type 2 DiabetesDiabetes Care, 2007
- Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinasesCell Research, 2006
- Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic miceBlood, 2006
- Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy WomenJama-Journal Of The American Medical Association, 2004
- The Snf1 Protein Kinase Controls the Induction of Genes of the Iron Uptake Pathway at the Diauxic Shift in Saccharomyces cerevisiaePublished by Elsevier BV ,2003